[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE530175T1 - THERAPEUTIC COMBINATION FOR PAINFUL MEDICAL CONDITIONS - Google Patents

THERAPEUTIC COMBINATION FOR PAINFUL MEDICAL CONDITIONS

Info

Publication number
ATE530175T1
ATE530175T1 AT07725884T AT07725884T ATE530175T1 AT E530175 T1 ATE530175 T1 AT E530175T1 AT 07725884 T AT07725884 T AT 07725884T AT 07725884 T AT07725884 T AT 07725884T AT E530175 T1 ATE530175 T1 AT E530175T1
Authority
AT
Austria
Prior art keywords
medical conditions
therapeutic combination
painful medical
painful
therapeutic
Prior art date
Application number
AT07725884T
Other languages
German (de)
Inventor
Bettina Beyreuther
Thomas Stoehr
Original Assignee
Ucb Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/506,578 external-priority patent/US20070048372A1/en
Priority claimed from PCT/EP2006/008171 external-priority patent/WO2007020103A2/en
Priority claimed from US11/506,577 external-priority patent/US20070042969A1/en
Priority claimed from US11/506,524 external-priority patent/US20070043120A1/en
Application filed by Ucb Pharma Gmbh filed Critical Ucb Pharma Gmbh
Application granted granted Critical
Publication of ATE530175T1 publication Critical patent/ATE530175T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT07725884T 2006-06-08 2007-06-06 THERAPEUTIC COMBINATION FOR PAINFUL MEDICAL CONDITIONS ATE530175T1 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US81184006P 2006-06-08 2006-06-08
US81185906P 2006-06-08 2006-06-08
US11/506,578 US20070048372A1 (en) 2005-08-18 2006-08-18 Method for treating non-inflammatory osteoarthritic pain
PCT/EP2006/008171 WO2007020103A2 (en) 2005-08-18 2006-08-18 Novel use of peptide compounds for treating muscle pain
US11/506,523 US20070197657A1 (en) 2005-08-18 2006-08-18 Method for treating non-inflammatory musculoskeletal pain
US11/506,577 US20070042969A1 (en) 2004-03-26 2006-08-18 Combination therapy for pain in painful diabetic neuropathy
US11/506,524 US20070043120A1 (en) 2005-08-18 2006-08-18 Therapeutic combination for painful medical conditions
PCT/EP2007/005036 WO2007141018A1 (en) 2006-06-08 2007-06-06 Therapeutic combination for painful medical conditions

Publications (1)

Publication Number Publication Date
ATE530175T1 true ATE530175T1 (en) 2011-11-15

Family

ID=46964866

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07725884T ATE530175T1 (en) 2006-06-08 2007-06-06 THERAPEUTIC COMBINATION FOR PAINFUL MEDICAL CONDITIONS

Country Status (11)

Country Link
JP (1) JP2009539792A (en)
KR (1) KR20090018863A (en)
AR (1) AR061250A1 (en)
AT (1) ATE530175T1 (en)
AU (1) AU2007256352A1 (en)
BR (1) BRPI0712494A2 (en)
CA (1) CA2652667A1 (en)
EA (1) EA200802412A1 (en)
MX (1) MX2008015341A (en)
TW (1) TW200814988A (en)
WO (1) WO2007141018A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200846002A (en) * 2007-03-15 2008-12-01 Astellas Pharma Inc Novel prophylactic and/or therapeutic agent for diabetic neuropathy
TW200846003A (en) * 2007-03-15 2008-12-01 Astellas Pharma Inc Novel prophylactic and/or therapeutic agent for diabetic neuropathy
EP2116539A1 (en) 2008-04-25 2009-11-11 Laboratorios Del. Dr. Esteve, S.A. 1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof
US20110152268A1 (en) * 2008-09-11 2011-06-23 Astellas Pharma Inc. Novel pharmaceutical composition for treating nociceptive pain
US8198268B2 (en) 2008-10-31 2012-06-12 Janssen Biotech, Inc. Tianeptine sulfate salt forms and methods of making and using the same
EP2353591A1 (en) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof
EP2353598A1 (en) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for use in the prevention and/or treatment of postoperative pain
EP2388005A1 (en) 2010-05-21 2011-11-23 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy
KR101831616B1 (en) 2010-06-15 2018-04-04 그뤼넨탈 게엠베하 Pharmaceutical combination for the treatment of pain
EP2415471A1 (en) 2010-08-03 2012-02-08 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in opioid-induced hyperalgesia
EP2524694A1 (en) * 2011-05-19 2012-11-21 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in diabetes type-2 associated pain
EP2922536A4 (en) * 2012-11-20 2016-06-08 Revive Therapeutics Inc The use of bucillamine in the treatment of gout
US9662305B2 (en) 2012-11-20 2017-05-30 Revive Therapeutics Inc. Use of bucillamine in the treatment of gout
EP3082782A1 (en) 2013-12-17 2016-10-26 Laboratorios Del. Dr. Esteve, S.A. SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIs) AND SIGMA RECEPTOR LIGANDS COMBINATIONS
CN114306346A (en) * 2021-12-14 2022-04-12 四川大学华西医院 Application of lamotrigine in treatment of systemic lupus erythematosus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1243262T3 (en) * 2001-03-20 2006-10-02 Sanol Arznei Schwarz Gmbh Hitherto unknown use of a peptide class of compounds to treat non-neuropathic inflammatory pain
US7794987B2 (en) * 2003-12-02 2010-09-14 Ucb Pharma Gmbh Method for treating central neuropathic pain
EP1579858A1 (en) * 2004-03-26 2005-09-28 Schwarz Pharma Ag Novel use of peptide compounds for treating pain in painful diabetic neuropathy
CA2562937A1 (en) * 2004-04-16 2005-10-27 Schwarz Pharma Ag Use of peptidic compounds for the prophylaxis and treatment of chronic headache
RU2006139930A (en) * 2004-05-03 2008-06-10 Дюк Юниверсити (Сша/Сша) (Us) COMPOSITIONS FOR PROMOTING WEIGHT LOSS

Also Published As

Publication number Publication date
CA2652667A1 (en) 2007-12-13
AR061250A1 (en) 2008-08-13
KR20090018863A (en) 2009-02-23
JP2009539792A (en) 2009-11-19
WO2007141018A1 (en) 2007-12-13
BRPI0712494A2 (en) 2012-10-09
MX2008015341A (en) 2009-02-10
TW200814988A (en) 2008-04-01
EA200802412A1 (en) 2009-06-30
AU2007256352A1 (en) 2007-12-13

Similar Documents

Publication Publication Date Title
ATE530175T1 (en) THERAPEUTIC COMBINATION FOR PAINFUL MEDICAL CONDITIONS
LTPA2018006I1 (en) Combined Oxazolidinone Combination Therapy
LTC2787345I2 (en) Remedies for treatment of Fabri disease
DE502007004174D1 (en) Marker composite for medical implants
DE602007006594D1 (en) Endoscope treatment instrument
DE602007009881D1 (en) Packaging for medical devices
DK2018206T3 (en) Bandages for medical use
BRPI0811265A2 (en) TREATMENT OF SYNUCLEINOPATHIES
DK2083774T3 (en) Therapeutic intravaginal device
ES2402426T8 (en) Medical probe
DE602007009037D1 (en) Medical device
DK2170432T3 (en) Flexible medical cannula
BRPI0916931A2 (en) therapeutic agents
DK2144905T3 (en) Therapeutic agents
DE602007011342D1 (en) Endoscope treatment tool
DK2035369T3 (en) THERAPEUTIC
BRPI0815551A2 (en) TREATMENT THROUGH HUCBC OF BETA-AMYLOID DISEASE
DE602006013907D1 (en) Safety shield system for medical needles
DK1993589T3 (en) Treatments for neurological diseases
DE602007001713D1 (en) Medical tube arrangement
BRPI0818598A2 (en) therapeutic agents - 802
BRPI0716742A2 (en) Therapeutic Lactams
SMT201600041B (en) THERAPEUTIC AGENTS 713
BRPI0716374A2 (en) "medical devices"
ATE481469T1 (en) TISSUE CARE COMPOSITIONS

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties